Institutional Ownership Ani Pharmaceuticals Inc (ANIP)
This table provides information about the institutional ownership of Ani Pharmaceuticals Inc (ANIP). We have compiled data on the 243 institutions that hold shares in the stock, with a total of 20 Million shares, which have been reported (via 13F filing form) to have a value of $1.9 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Royal Bank Of Canada
Toronto, A6 |
Aug 14, 2025 Q2 2025 |
212,083
shares
|
$20.2 Million
0.0% of portfolio
|
Q2 2025
Added 0.8%
|
|
|
Loomis Sayles & CO L P
|
Aug 13, 2025 Q2 2025 |
206,382
shares
|
$19.6 Million
0.02% of portfolio
|
Q2 2025
Added 6.44%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Aug 14, 2025 Q2 2025 |
205,620
shares
|
$19.6 Million
0.0% of portfolio
|
Q2 2025
Reduced 67.45%
|
|
|
Morgan Stanley
New York, NY |
Aug 15, 2025 Q2 2025 |
200,876
shares
|
$19.1 Million
0.0% of portfolio
|
Q2 2025
Reduced 54.08%
|
|
|
Freestone Grove Partners LP
San Francisco, CA |
Aug 14, 2025 Q2 2025 |
195,214
shares
|
$18.6 Million
0.1% of portfolio
|
Q2 2025
Added 4784.01%
|
|
|
Northern Trust Corp
Chicago, IL |
Aug 13, 2025 Q2 2025 |
189,473
shares
|
$18 Million
0.0% of portfolio
|
Q2 2025
Reduced 12.63%
|
|
|
Bank Of America Corp
Charlotte, NC |
Aug 14, 2025 Q2 2025 |
185,465
shares
|
$17.7 Million
0.0% of portfolio
|
Q2 2025
Added 31.96%
|
|
|
Barclays PLC
London, X0 |
Aug 14, 2025 Q2 2025 |
184,639
shares
|
$17.6 Million
0.0% of portfolio
|
Q2 2025
Added 32.57%
|
|
|
Invesco Ltd.
Atlanta, GA |
Aug 13, 2025 Q2 2025 |
172,457
shares
|
$16.4 Million
0.0% of portfolio
|
Q2 2025
Reduced 13.58%
|
|
|
Russell Investments Group, Ltd.
|
Aug 13, 2025 Q2 2025 |
166,947
shares
|
$15.9 Million
0.01% of portfolio
|
Q2 2025
Reduced 9.99%
|
|
|
Principal Financial Group Inc
Des Moines, IA |
Aug 08, 2025 Q2 2025 |
150,805
shares
|
$14.4 Million
0.01% of portfolio
|
Q2 2025
Reduced 4.43%
|
|
|
Teacher Retirement System Of Texas
Austin, TX |
Aug 01, 2025 Q2 2025 |
147,380
shares
|
$14 Million
0.04% of portfolio
|
Q2 2025
Added 3156.3%
|
|
|
Oberweis Asset Management Inc
Lisle, IL |
Aug 14, 2025 Q2 2025 |
138,900
shares
|
$13.2 Million
0.43% of portfolio
|
Q2 2025
Added 111.74%
|
|
|
Parkman Healthcare Partners LLC
Stamford, CT |
Aug 14, 2025 Q2 2025 |
128,478
shares
|
$12.2 Million
1.12% of portfolio
|
Q2 2025
Added 22.36%
|
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
Aug 13, 2025 Q2 2025 |
128,387
shares
|
$12.2 Million
0.01% of portfolio
|
Q2 2025
Reduced 41.51%
|
|
|
Apis Capital Advisors, LLC
New York, NY |
Aug 13, 2025 Q2 2025 |
128,000
shares
|
$12.2 Million
4.15% of portfolio
|
Q2 2025
Added 96.92%
|
|
|
Sio Capital Management, LLC
New York, NY |
Aug 13, 2025 Q2 2025 |
112,923
shares
|
$10.8 Million
3.52% of portfolio
|
Q2 2025
Added 29.35%
|
|
|
Raymond James Financial Inc
St. Petersburg, FL |
Aug 14, 2025 Q2 2025 |
97,699
shares
|
$9.3 Million
0.0% of portfolio
|
Q2 2025
Reduced 2.46%
|
|
|
Lisanti Capital Growth, LLC
|
Aug 07, 2025 Q2 2025 |
95,165
shares
|
$9.06 Million
2.02% of portfolio
|
Q2 2025
Reduced 9.73%
|
|
|
Hotchkis & Wiley Capital Management LLC
Los Angeles, CA |
Aug 13, 2025 Q2 2025 |
86,610
shares
|
$8.25 Million
0.02% of portfolio
|
Q2 2025
Reduced 20.25%
|
|
|
First Trust Advisors LP
Wheaton, IL |
Aug 13, 2025 Q2 2025 |
81,214
shares
|
$7.73 Million
0.0% of portfolio
|
Q2 2025
Added 128.12%
|
|
|
Victory Capital Management Inc
|
Aug 13, 2025 Q2 2025 |
79,704
shares
|
$7.59 Million
0.0% of portfolio
|
Q2 2025
Added 372.66%
|
|
|
Wells Fargo & Company
San Francisco, CA |
Aug 14, 2025 Q2 2025 |
78,635
shares
|
$7.49 Million
0.0% of portfolio
|
Q2 2025
Added 704.12%
|
|
|
Qube Research & Technologies LTD
London, X0 |
Aug 14, 2025 Q2 2025 |
76,185
shares
|
$7.25 Million
0.01% of portfolio
|
Q2 2025
Added 113.38%
|
|
|
Marathon Capital Management
Hunt Valley, MD |
Aug 14, 2025 Q2 2025 |
72,025
shares
|
$6.86 Million
1.25% of portfolio
|
Q2 2025
Added 4.09%
|